Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Feb 15, 2022 8:27am
308 Views
Post# 34429187

RE:PR - taking contract sales force inhouse

RE:PR - taking contract sales force inhouseWino - I really wish they could ask you to wrote their PR's for them. You have already put together some great prot-types and I am confident you would never put something like "positive headwinds" in anything you wrote! But, at least they solved the problem of press releases that never were released by the press! 

I know THTX is a small company where things like that are more prone to happen and that "positive headwinds" is a very minor issue but it is disconcerting that no one caught that before it was sent out. Still, I am looking for THTX to demonstrate excellence in even these little issues.

Any sales transition is apt to lead to a blip in short term sales but this is making THTX look more like a real drug company and is likely being done at least partly in preparation for future hoped-for cancer drug sales. I would be curious to know what the financial implications are - perhaps we will get their spin on that during the conference call.

I am sure the new CCO said to Paul he did not want to be dealing with the external sales partner and really pushed for this. He came from Pfizer and probably had no time for such an arrangementeven if it offerd tax benefits, which was my understanding of one of the reasons for it beingset up this way in the first place. The question is if the cost of the move will offset its benefits but I suspect neither will be too significant in the end. It also could just be a way to blame the inability to reach their lofty sales goals for Egrifta and Trogarzo on something other than the fact that those goals are likely unrealistically high.

Wino115 wrote:

I believe this had to be PRed because it would be considered material.  There's a few "message" points embedded in it that are positive.  


-big enough future to support sales 
-design the skills you want (HIV and oncology)?
-way to cherry pick the better people and ditch underperformers
-likely new CCO and HR skills allow this inhouse
-expects sales or margin pickup?

Someone needs to tell them a positive headwind is called a "tailwind".  



 



<< Previous
Bullboard Posts
Next >>